|
|
||||||||
Department of Radiology, Division of Nuclear Medicine, University of Utah School of Medicine, Salt Lake City, Utah
Correspondence: For correspondence or reprints contact: Frederick L. Datz, MD, Director of Nuclear Medicine, Department of Radiology, University of Utah Medical Center, Salt Lake City, UT 84132.
ABSTRACT
A patient with known aortoiliac occlusive disease and hypertension suffered a cerebrovascular accident 6.5 min after the administration of intravenous dipyridamole during a 201Tl myocardial study. Despite aminophylline administration, the patient developed a completed stroke. The mechanism most likely responsible for precipitating this patient's stroke is dipyridamole-induced vascular steal. Although dipyridamole-201Tl myocardial imaging is relatively free of major complications, the morbidity and mortality associated with a cerebrovascular accident is significant. The possibility of precipitating a cerebrovascular accident during dipyridamole-201Tl imaging should be considered in all patients with significant risk factors for stroke before performing a dipyridamole cardiac study.
This article has been cited by other articles:
![]() |
H. Ito, T. Kinoshita, Y. Tamura, I. Yokoyama, and H. Iida Effect of Intravenous Dipyridamole on Cerebral Blood Flow in Humans : A PET Study Stroke, August 1, 1999; 30(8): 1616 - 1620. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |